View in EDS

Low Dose Tocilizumab for Mitigation of Cytokine Release Syndrome With T-Cell Engaging Bispecific Antibodies.

Saved in:
Bibliographic Details
Title: Low Dose Tocilizumab for Mitigation of Cytokine Release Syndrome With T-Cell Engaging Bispecific Antibodies.
Authors: Hamadeh IS; Memorial Sloan Kettering Cancer Center, Clinical Pharmacy Services, New York, NY., Merz M; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY., Derkach A; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY., Modelevsky L; Memorial Sloan Kettering Cancer Center, Clinical Pharmacy Services, New York, NY., Lesokhin AM; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY., Mailankody S; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY., Hultcrantz ML; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY., Tan CR; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY., Hassoun H; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY., Shah UA; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY., Maclachlan K; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY., Rajeeve S; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY., Hashmi H; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY., Maura F; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY., Firestone RS; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY., Wang AX; Memorial Sloan Kettering Cancer Center, Clinical Pharmacy Services, New York, NY., Amin A; Memorial Sloan Kettering Cancer Center, Clinical Pharmacy Services, New York, NY., Patel D; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY., Scordo M; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Transplant and Cellular Therapy Services, New York, NY., Shah GL; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Transplant and Cellular Therapy Services, New York, NY., Landau HJ; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Transplant and Cellular Therapy Services, New York, NY., Giralt S; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Transplant and Cellular Therapy Services, New York, NY., Usmani SZ; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY., Korde N; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY. Electronic address: korden@mskcc.org.
Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2026 Jun; Vol. 26 (6), pp. e802-e810. Date of Electronic Publication: 2026 Mar 27.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42036267
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Low Dose Tocilizumab for Mitigation of Cytokine Release Syndrome With T-Cell Engaging Bispecific Antibodies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hamadeh+IS%22">Hamadeh IS</searchLink>; Memorial Sloan Kettering Cancer Center, Clinical Pharmacy Services, New York, NY.<br /><searchLink fieldCode="AU" term="%22Merz+M%22">Merz M</searchLink>; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY.<br /><searchLink fieldCode="AU" term="%22Derkach+A%22">Derkach A</searchLink>; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY.<br /><searchLink fieldCode="AU" term="%22Modelevsky+L%22">Modelevsky L</searchLink>; Memorial Sloan Kettering Cancer Center, Clinical Pharmacy Services, New York, NY.<br /><searchLink fieldCode="AU" term="%22Lesokhin+AM%22">Lesokhin AM</searchLink>; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY.<br /><searchLink fieldCode="AU" term="%22Mailankody+S%22">Mailankody S</searchLink>; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY.<br /><searchLink fieldCode="AU" term="%22Hultcrantz+ML%22">Hultcrantz ML</searchLink>; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY.<br /><searchLink fieldCode="AU" term="%22Tan+CR%22">Tan CR</searchLink>; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY.<br /><searchLink fieldCode="AU" term="%22Hassoun+H%22">Hassoun H</searchLink>; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY.<br /><searchLink fieldCode="AU" term="%22Shah+UA%22">Shah UA</searchLink>; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY.<br /><searchLink fieldCode="AU" term="%22Maclachlan+K%22">Maclachlan K</searchLink>; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY.<br /><searchLink fieldCode="AU" term="%22Rajeeve+S%22">Rajeeve S</searchLink>; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY.<br /><searchLink fieldCode="AU" term="%22Hashmi+H%22">Hashmi H</searchLink>; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY.<br /><searchLink fieldCode="AU" term="%22Maura+F%22">Maura F</searchLink>; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY.<br /><searchLink fieldCode="AU" term="%22Firestone+RS%22">Firestone RS</searchLink>; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY.<br /><searchLink fieldCode="AU" term="%22Wang+AX%22">Wang AX</searchLink>; Memorial Sloan Kettering Cancer Center, Clinical Pharmacy Services, New York, NY.<br /><searchLink fieldCode="AU" term="%22Amin+A%22">Amin A</searchLink>; Memorial Sloan Kettering Cancer Center, Clinical Pharmacy Services, New York, NY.<br /><searchLink fieldCode="AU" term="%22Patel+D%22">Patel D</searchLink>; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY.<br /><searchLink fieldCode="AU" term="%22Scordo+M%22">Scordo M</searchLink>; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Transplant and Cellular Therapy Services, New York, NY.<br /><searchLink fieldCode="AU" term="%22Shah+GL%22">Shah GL</searchLink>; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Transplant and Cellular Therapy Services, New York, NY.<br /><searchLink fieldCode="AU" term="%22Landau+HJ%22">Landau HJ</searchLink>; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Transplant and Cellular Therapy Services, New York, NY.<br /><searchLink fieldCode="AU" term="%22Giralt+S%22">Giralt S</searchLink>; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Transplant and Cellular Therapy Services, New York, NY.<br /><searchLink fieldCode="AU" term="%22Usmani+SZ%22">Usmani SZ</searchLink>; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY.<br /><searchLink fieldCode="AU" term="%22Korde+N%22">Korde N</searchLink>; Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Myeloma Service, New York, NY. Electronic address: korden@mskcc.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101525386%22">Clinical lymphoma, myeloma & leukemia</searchLink> [Clin Lymphoma Myeloma Leuk] 2026 Jun; Vol. 26 (6), pp. e802-e810. <i>Date of Electronic Publication: </i>2026 Mar 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101525386 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2152-2669 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221522669%22">21522669 </searchLink><i>NLM ISO Abbreviation: </i>Clin Lymphoma Myeloma Leuk <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42036267
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.clml.2026.03.016
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e802
    Titles:
      – TitleFull: Low Dose Tocilizumab for Mitigation of Cytokine Release Syndrome With T-Cell Engaging Bispecific Antibodies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hamadeh IS
      – PersonEntity:
          Name:
            NameFull: Merz M
      – PersonEntity:
          Name:
            NameFull: Derkach A
      – PersonEntity:
          Name:
            NameFull: Modelevsky L
      – PersonEntity:
          Name:
            NameFull: Lesokhin AM
      – PersonEntity:
          Name:
            NameFull: Mailankody S
      – PersonEntity:
          Name:
            NameFull: Hultcrantz ML
      – PersonEntity:
          Name:
            NameFull: Tan CR
      – PersonEntity:
          Name:
            NameFull: Hassoun H
      – PersonEntity:
          Name:
            NameFull: Shah UA
      – PersonEntity:
          Name:
            NameFull: Maclachlan K
      – PersonEntity:
          Name:
            NameFull: Rajeeve S
      – PersonEntity:
          Name:
            NameFull: Hashmi H
      – PersonEntity:
          Name:
            NameFull: Maura F
      – PersonEntity:
          Name:
            NameFull: Firestone RS
      – PersonEntity:
          Name:
            NameFull: Wang AX
      – PersonEntity:
          Name:
            NameFull: Amin A
      – PersonEntity:
          Name:
            NameFull: Patel D
      – PersonEntity:
          Name:
            NameFull: Scordo M
      – PersonEntity:
          Name:
            NameFull: Shah GL
      – PersonEntity:
          Name:
            NameFull: Landau HJ
      – PersonEntity:
          Name:
            NameFull: Giralt S
      – PersonEntity:
          Name:
            NameFull: Usmani SZ
      – PersonEntity:
          Name:
            NameFull: Korde N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2026 Jun
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2152-2669
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Clinical lymphoma, myeloma & leukemia
              Type: main
ResultId 1